Interlink Electronics at Lytham Partners summit: growth beyond turnaround

On Tuesday, 18 August 2026, Interlink Electronics (LINK) attended the Lytham Partners 2026 Consumer & Technology Investor Summit to position itself as a company transitioning from a turnaround phase to a broader growth story. CEO Steven Bronson highlighted the company's expansion across sensors, printed electronics, medical devices, smart textiles, and AI-linked applications.

Despite facing typical challenges like lengthy sales cycles, acquisition integration, and margin preservation, Bronson emphasized that Interlink is no longer operating as a distressed company.

The business has moved beyond cleanup work and is now concentrating on scaling a wider technology platform. Bronson explained that the company is not solely focused on price-driven deals but is leveraging proprietary software, firmware, and application expertise to achieve higher margins, particularly in medical and specialized markets.

Despite highlighting the sharp rise in revenue and reaching break-even, Bronson noted that growth has resulted from both organic expansion and acquisitions, though he did not specify the proportion of each.

Interlink's market capitalization is currently $81.4 million, with a gross profit margin of approximately 41%. While analysts project a 40% sales growth for the current year, they do not expect profitability this year, which contrasts with management's claims of breaking even. The stock is currently valued as overvalued according to InvestingPro's Fair Value analysis, putting it on the Most Overvalued list.

Investors can delve deeper into the company through the Pro Research Report available for LINK and over 1,400 other US equities on InvestingPro.

Bronson discussed Interlink's "InterLink 2.0" strategy, designed to diversify technologies, capabilities, and customer bases, thereby reducing dependence on any single product line or market. He emphasized that the company supplies sensors and data-capture tools for AI systems, positioning itself in the growing physical AI sector, especially in robotics and medical applications.

The company's growth remains anchored in medical devices, where long design cycles and long-lasting customer relationships create stable revenue streams. Interlink has achieved growth through internal development and selective acquisitions, aiming to keep risks under control by preserving core teams and physical locations.

The company's financial health supports this acquisition strategy, with liquid assets exceeding short-term obligations and a current ratio of 4.58, while the debt-to-equity ratio is a modest 0.11. During the Q&A session, Bronson reiterated the importance of margin protection, shareholder alignment, and the role of acquisitions in future growth.

He acknowledged investor preferences for trading liquidity but stressed that stock performance will ultimately hinge on execution, revenue growth, and earnings growth. Bronson also hinted at potential future equity capital raises to support growth and attract more institutional investors. Management highlighted external trends that could bolster demand but also acknowledged the challenges associated with their markets.

Bronson concluded by focusing on building on recent progress rather than proving the turnaround itself, aiming to expand the portfolio while maintaining discipline on valuation, debt, and execution.